Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • ALESION ® - Dermatitis, Atopic
    Clinical Study Number 262.259
    Study Indication Dermatitis, Atopic
    Product ALESION ®
    Generic Name Epinastine
    Lab Code
    Clinical Phase III
    Study Title

    Phase III Double-Blind Comparative Study of WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

    Study Document
    Trial synopsis 262.259 english
  • ALESION ® - Dermatitis, Atopic
    Clinical Study Number 262.260
    Study Indication Dermatitis, Atopic
    Product ALESION ®
    Generic Name Epinastine
    Lab Code
    Clinical Phase III
    Study Title

    Phase III Open-labeled Study of WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

    Study Document
    Trial synopsis 262.260 english